166 related articles for article (PubMed ID: 21974896)
1. Lymph vessel density in seminomatous testicular cancer assessed with the specific lymphatic endothelium cell markers D2-40 and LYVE-1: correlation with pathologic parameters and clinical outcome.
Heinzelbecker J; Kempf KM; Kurz K; Steidler A; Weiss C; Jackson DG; Bolenz C; Haecker A; Trojan L
Urol Oncol; 2013 Oct; 31(7):1386-94. PubMed ID: 21974896
[TBL] [Abstract][Full Text] [Related]
2. The role of lymph vessel density and lymphangiogenesis in metastatic tumor spread of nonseminomatous testicular germ cell tumors.
Heinzelbecker J; Gropp T; Weiss C; Huettl K; Stroebel P; Haecker A; Bolenz C; Trojan L
Urol Oncol; 2014 Feb; 32(2):178-85. PubMed ID: 23141777
[TBL] [Abstract][Full Text] [Related]
3. The lymphatic system in clinically localized urothelial carcinoma of the bladder: morphologic characteristics and predictive value.
Bolenz C; Auer M; Ströbel P; Heinzelbecker J; Schubert C; Trojan L
Urol Oncol; 2013 Nov; 31(8):1606-14. PubMed ID: 22503575
[TBL] [Abstract][Full Text] [Related]
4. Different significance between intratumoral and peritumoral lymphatic vessel density in gastric cancer: a retrospective study of 123 cases.
Wang XL; Fang JP; Tang RY; Chen XM
BMC Cancer; 2010 Jun; 10():299. PubMed ID: 20565772
[TBL] [Abstract][Full Text] [Related]
5. High density of peritumoral lymphatic vessels measured by D2-40/podoplanin and LYVE-1 expression in gastric cancer patients: an excellent prognostic indicator or a false friend?
Rudno-Rudzinska J; Kielan W; Grzebieniak Z; Dziegiel P; Donizy P; Mazur G; Knakiewicz M; Frejlich E; Halon A
Gastric Cancer; 2013 Oct; 16(4):513-20. PubMed ID: 23238856
[TBL] [Abstract][Full Text] [Related]
6. Intratumoral but not peritumoral lymphatic vessel density measured by D2-40 expression predicts poor outcome in gastric cancer--ROC curve analysis to find cut-off point.
Donizy P; Rudno-Rudzinska J; Halon A; Dziegala M; Kabarowski J; Frejlich E; Dziegiel P; Kielan W; Matkowski R
Anticancer Res; 2014 Jun; 34(6):3113-8. PubMed ID: 24922680
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of peritumoral lymphatic vessel density and lymphatic vessel invasion detected by D2-40 immunostaining in FIGO Ib1-IIa squamous cell cervical cancer.
Xiong Y; Cao LP; Rao HL; Cai MY; Liang LZ; Liu JH
Cell Tissue Res; 2012 Jun; 348(3):515-22. PubMed ID: 22492093
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical and immunofluorescence expression profile of lymphatic endothelial cell markers in oral cancer.
Chutipongpisit K; Parachuru VP; Friedlander LT; Hussaini HM; Rich AM
Int J Exp Pathol; 2021 Dec; 102(6):268-278. PubMed ID: 34791715
[TBL] [Abstract][Full Text] [Related]
9. [Association between lymphangiogenesis and clinicopathological features and prognosis in laryngeal carcinoma].
Zou JD; Fu HY; Xu W; Lü ZH; Cao HY; Luan XY
Zhonghua Zhong Liu Za Zhi; 2011 Jun; 33(6):461-4. PubMed ID: 21875489
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Significance of Lymphatic Vessel Density Detected by D2-40 and Its Relation to Claudin-4 Expression in Prostatic Adenocarcinoma.
Radi DA; Abd-Elazeem MA
Int J Surg Pathol; 2016 May; 24(3):219-26. PubMed ID: 26464161
[TBL] [Abstract][Full Text] [Related]
11. Peritumoral lymphangiogenesis induced by vascular endothelial growth factor C and D promotes lymph node metastasis in breast cancer patients.
Zhao YC; Ni XJ; Li Y; Dai M; Yuan ZX; Zhu YY; Luo CY
World J Surg Oncol; 2012 Aug; 10():165. PubMed ID: 22906075
[TBL] [Abstract][Full Text] [Related]
12. Lymph and blood vessel architecture in benign and malignant prostatic tissue: lack of lymphangiogenesis in prostate carcinoma assessed with novel lymphatic marker lymphatic vessel endothelial hyaluronan receptor (LYVE-1).
Trojan L; Michel MS; Rensch F; Jackson DG; Alken P; Grobholz R
J Urol; 2004 Jul; 172(1):103-7. PubMed ID: 15201747
[TBL] [Abstract][Full Text] [Related]
13. Can lymphatic vascular density be used in determining metastatic spreading potential of tumor in invasive ductal carcinomas?
Kandemir NO; Barut F; Bektas S; Ozdamar SO
Pathol Oncol Res; 2012 Apr; 18(2):253-62. PubMed ID: 21785902
[TBL] [Abstract][Full Text] [Related]
14. Tumour expression of lymphangiogenic growth factors but not lymphatic vessel density is implicated in human cervical cancer progression.
Sotiropoulou N; Bravou V; Kounelis S; Damaskou V; Papaspirou E; Papadaki H
Pathology; 2010 Dec; 42(7):629-36. PubMed ID: 21080871
[TBL] [Abstract][Full Text] [Related]
15. Relationship between high density of peritumoral lymphatic vessels and biological behavior of cervical cancer.
En-Lin S; Wei-Wei Y; Xiao-Liang X; Juan X
Int J Gynecol Cancer; 2012 Oct; 22(8):1435-41. PubMed ID: 22968518
[TBL] [Abstract][Full Text] [Related]
16. Lymphatic vessel density as prognostic factor in breast carcinoma: relation to clinicopathologic parameters.
El-Gendi S; Abdel-Hadi M
J Egypt Natl Canc Inst; 2009 Jun; 21(2):139-49. PubMed ID: 21057565
[TBL] [Abstract][Full Text] [Related]
17. Detection of lymphangiogenesis in non-small cell lung cancer and its prognostic value.
Sun JG; Wang Y; Chen ZT; Zhuo WL; Zhu B; Liao RX; Zhang SX
J Exp Clin Cancer Res; 2009 Feb; 28(1):21. PubMed ID: 19216806
[TBL] [Abstract][Full Text] [Related]
18. Prognostic implications of lymphangiogenesis in muscle-invasive transitional cell carcinoma of the bladder.
Fernández MI; Bolenz C; Trojan L; Steidler A; Weiss C; Alken P; Grobholz R; Michel MS
Eur Urol; 2008 Mar; 53(3):571-8. PubMed ID: 17804149
[TBL] [Abstract][Full Text] [Related]
19. [Lymphatic vessel density in Dukes' B rectal carcinoma and its correlation to prognosis].
Yang X; Li LR; Pan ZZ; Zhou ZW; Wan DS
Ai Zheng; 2006 Jun; 25(6):749-52. PubMed ID: 16764774
[TBL] [Abstract][Full Text] [Related]
20. Tight junction protein claudin 4 in gastric carcinoma and its relation to lymphangiogenic activity.
Shareef MM; Radi DM; Eid AM
Arab J Gastroenterol; 2015; 16(3-4):105-12. PubMed ID: 26526513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
